
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_2{left:69px;top:103px;word-spacing:2.4px;}
#t2_2{left:69px;top:121px;letter-spacing:0.1px;word-spacing:-0.1px;}
#t3_2{left:87px;top:140px;word-spacing:26.9px;}
#t4_2{left:69px;top:158px;letter-spacing:0.1px;word-spacing:8.2px;}
#t5_2{left:69px;top:176px;word-spacing:32.6px;}
#t6_2{left:69px;top:195px;word-spacing:25px;}
#t7_2{left:69px;top:213px;word-spacing:38px;}
#t8_2{left:69px;top:231px;word-spacing:21.7px;}
#t9_2{left:69px;top:249px;word-spacing:29.3px;}
#ta_2{left:69px;top:268px;letter-spacing:0.1px;word-spacing:4.3px;}
#tb_2{left:69px;top:286px;letter-spacing:0.1px;}
#tc_2{left:161px;top:284px;}
#td_2{left:175px;top:286px;letter-spacing:0.1px;word-spacing:12.7px;}
#te_2{left:69px;top:304px;word-spacing:2.7px;}
#tf_2{left:69px;top:322px;word-spacing:7.9px;}
#tg_2{left:69px;top:341px;word-spacing:10px;}
#th_2{left:418px;top:339px;}
#ti_2{left:69px;top:359px;letter-spacing:0.1px;word-spacing:5.1px;}
#tj_2{left:69px;top:377px;word-spacing:7.4px;}
#tk_2{left:236px;top:375px;}
#tl_2{left:242px;top:375px;}
#tm_2{left:251px;top:375px;}
#tn_2{left:263px;top:377px;letter-spacing:0.1px;word-spacing:7.1px;}
#to_2{left:69px;top:395px;word-spacing:4.5px;}
#tp_2{left:69px;top:414px;word-spacing:5.2px;}
#tq_2{left:289px;top:412px;}
#tr_2{left:87px;top:432px;word-spacing:33.9px;}
#ts_2{left:69px;top:450px;word-spacing:15.6px;}
#tt_2{left:69px;top:469px;word-spacing:37.9px;}
#tu_2{left:69px;top:487px;letter-spacing:0.1px;word-spacing:15.7px;}
#tv_2{left:69px;top:505px;}
#tw_2{left:110px;top:505px;}
#tx_2{left:164px;top:505px;}
#ty_2{left:190px;top:505px;}
#tz_2{left:263px;top:505px;letter-spacing:0.1px;}
#t10_2{left:315px;top:505px;letter-spacing:0.1px;}
#t11_2{left:380px;top:505px;letter-spacing:0.1px;}
#t12_2{left:69px;top:523px;word-spacing:19px;}
#t13_2{left:69px;top:542px;letter-spacing:0.1px;}
#t14_2{left:178px;top:540px;}
#t15_2{left:213px;top:542px;word-spacing:8.3px;}
#t16_2{left:69px;top:560px;word-spacing:24.1px;}
#t17_2{left:69px;top:578px;letter-spacing:0.1px;}
#t18_2{left:157px;top:576px;}
#t19_2{left:169px;top:576px;}
#t1a_2{left:178px;top:576px;}
#t1b_2{left:203px;top:578px;letter-spacing:0.1px;word-spacing:32.7px;}
#t1c_2{left:69px;top:596px;word-spacing:6.9px;}
#t1d_2{left:69px;top:615px;letter-spacing:0.1px;}
#t1e_2{left:153px;top:613px;}
#t1f_2{left:87px;top:633px;letter-spacing:0.1px;word-spacing:27.3px;}
#t1g_2{left:69px;top:651px;word-spacing:10px;}
#t1h_2{left:69px;top:669px;word-spacing:4.6px;}
#t1i_2{left:69px;top:688px;word-spacing:17.7px;}
#t1j_2{left:69px;top:706px;word-spacing:2.3px;}
#t1k_2{left:165px;top:704px;}
#t1l_2{left:182px;top:706px;word-spacing:2.6px;}
#t1m_2{left:69px;top:724px;word-spacing:2.8px;}
#t1n_2{left:69px;top:742px;word-spacing:4.2px;}
#t1o_2{left:69px;top:761px;word-spacing:11.9px;}
#t1p_2{left:69px;top:779px;word-spacing:25.3px;}
#t1q_2{left:69px;top:797px;letter-spacing:0.1px;word-spacing:4.9px;}
#t1r_2{left:87px;top:816px;word-spacing:6.4px;}
#t1s_2{left:69px;top:834px;word-spacing:7.7px;}
#t1t_2{left:69px;top:852px;word-spacing:8.4px;}
#t1u_2{left:69px;top:870px;letter-spacing:0.1px;word-spacing:4.9px;}
#t1v_2{left:69px;top:928px;word-spacing:5.4px;}
#t1w_2{left:69px;top:948px;word-spacing:16.3px;}
#t1x_2{left:69px;top:965px;word-spacing:4.7px;}
#t1y_2{left:69px;top:982px;word-spacing:3.8px;}
#t1z_2{left:69px;top:998px;word-spacing:14.4px;}
#t20_2{left:69px;top:1015px;word-spacing:8.4px;}
#t21_2{left:69px;top:1032px;word-spacing:11.5px;}
#t22_2{left:69px;top:1049px;word-spacing:13.2px;}
#t23_2{left:69px;top:1065px;word-spacing:2.3px;}
#t24_2{left:69px;top:1082px;word-spacing:-0.7px;}
#t25_2{left:69px;top:1099px;word-spacing:12.1px;}
#t26_2{left:69px;top:1116px;word-spacing:4.6px;}
#t27_2{left:489px;top:104px;word-spacing:13.1px;}
#t28_2{left:470px;top:120px;word-spacing:10.6px;}
#t29_2{left:470px;top:137px;word-spacing:4.1px;}
#t2a_2{left:470px;top:154px;word-spacing:8.2px;}
#t2b_2{left:470px;top:171px;word-spacing:14.4px;}
#t2c_2{left:470px;top:187px;word-spacing:16.6px;}
#t2d_2{left:470px;top:204px;word-spacing:4.1px;}
#t2e_2{left:470px;top:221px;word-spacing:9.4px;}
#t2f_2{left:470px;top:238px;word-spacing:10.6px;}
#t2g_2{left:470px;top:254px;word-spacing:28.9px;}
#t2h_2{left:470px;top:271px;word-spacing:7.4px;}
#t2i_2{left:470px;top:288px;word-spacing:12.9px;}
#t2j_2{left:470px;top:305px;word-spacing:4.6px;}
#t2k_2{left:489px;top:321px;word-spacing:13.5px;}
#t2l_2{left:470px;top:338px;word-spacing:8.2px;}
#t2m_2{left:470px;top:355px;word-spacing:3.5px;}
#t2n_2{left:470px;top:372px;word-spacing:19.3px;}
#t2o_2{left:470px;top:388px;word-spacing:0.9px;}
#t2p_2{left:470px;top:405px;word-spacing:10.7px;}
#t2q_2{left:470px;top:422px;word-spacing:1.8px;}
#t2r_2{left:470px;top:438px;word-spacing:4.7px;}
#t2s_2{left:489px;top:455px;word-spacing:3.4px;}
#t2t_2{left:470px;top:472px;word-spacing:10.9px;}
#t2u_2{left:470px;top:489px;word-spacing:15.7px;}
#t2v_2{left:470px;top:506px;word-spacing:15.5px;}
#t2w_2{left:470px;top:522px;word-spacing:9.4px;}
#t2x_2{left:470px;top:539px;word-spacing:15.9px;}
#t2y_2{left:572px;top:539px;}
#t2z_2{left:590px;top:539px;}
#t30_2{left:625px;top:539px;}
#t31_2{left:643px;top:539px;word-spacing:15.8px;}
#t32_2{left:709px;top:539px;}
#t33_2{left:720px;top:539px;word-spacing:15.7px;}
#t34_2{left:470px;top:556px;}
#t35_2{left:483px;top:556px;}
#t36_2{left:493px;top:556px;word-spacing:4.7px;}
#t37_2{left:470px;top:611px;}
#t38_2{left:470px;top:631px;word-spacing:24.5px;}
#t39_2{left:470px;top:649px;word-spacing:14.9px;}
#t3a_2{left:470px;top:667px;word-spacing:9.2px;}
#t3b_2{left:470px;top:686px;word-spacing:16.4px;}
#t3c_2{left:470px;top:704px;word-spacing:17.1px;}
#t3d_2{left:470px;top:768px;word-spacing:13.3px;}
#t3e_2{left:525px;top:768px;word-spacing:13.5px;}
#t3f_2{left:470px;top:781px;word-spacing:3.8px;}
#t3g_2{left:712px;top:807px;word-spacing:4px;}
#t3h_2{left:776px;top:807px;letter-spacing:-0.4px;word-spacing:4.6px;}
#t3i_2{left:470px;top:831px;word-spacing:3.8px;}
#t3j_2{left:733px;top:831px;}
#t3k_2{left:785px;top:831px;word-spacing:16.7px;}
#t3l_2{left:483px;top:845px;}
#t3m_2{left:784px;top:845px;word-spacing:28.4px;}
#t3n_2{left:483px;top:858px;}
#t3o_2{left:784px;top:858px;word-spacing:28.4px;}
#t3p_2{left:470px;top:872px;word-spacing:4px;}
#t3q_2{left:483px;top:886px;word-spacing:3.8px;}
#t3r_2{left:723px;top:886px;}
#t3s_2{left:741px;top:886px;}
#t3t_2{left:790px;top:886px;}
#t3u_2{left:811px;top:886px;}
#t3v_2{left:483px;top:899px;word-spacing:3.8px;}
#t3w_2{left:723px;top:899px;}
#t3x_2{left:741px;top:899px;}
#t3y_2{left:790px;top:899px;}
#t3z_2{left:811px;top:899px;}
#t40_2{left:483px;top:913px;}
#t41_2{left:723px;top:913px;}
#t42_2{left:741px;top:913px;}
#t43_2{left:790px;top:913px;}
#t44_2{left:811px;top:913px;}
#t45_2{left:483px;top:927px;letter-spacing:-0.2px;word-spacing:4.2px;}
#t46_2{left:723px;top:927px;}
#t47_2{left:741px;top:927px;}
#t48_2{left:790px;top:927px;}
#t49_2{left:811px;top:927px;}
#t4a_2{left:495px;top:951px;letter-spacing:-0.7px;}
#t4b_2{left:718px;top:951px;word-spacing:4.2px;}
#t4c_2{left:785px;top:951px;word-spacing:3.8px;}
#t4d_2{left:483px;top:972px;word-spacing:3.8px;}
#t4e_2{left:718px;top:972px;}
#t4f_2{left:741px;top:972px;}
#t4g_2{left:784px;top:972px;word-spacing:28.4px;}
#t4h_2{left:483px;top:986px;word-spacing:4px;}
#t4i_2{left:718px;top:986px;}
#t4j_2{left:741px;top:986px;}
#t4k_2{left:784px;top:986px;word-spacing:28.4px;}
#t4l_2{left:483px;top:1000px;}
#t4m_2{left:718px;top:1000px;}
#t4n_2{left:741px;top:1000px;}
#t4o_2{left:784px;top:1000px;word-spacing:28.4px;}
#t4p_2{left:483px;top:1014px;word-spacing:4px;}
#t4q_2{left:724px;top:1014px;}
#t4r_2{left:747px;top:1014px;}
#t4s_2{left:790px;top:1014px;}
#t4t_2{left:811px;top:1014px;}
#t4u_2{left:483px;top:1027px;word-spacing:3.9px;}
#t4v_2{left:723px;top:1027px;word-spacing:28.4px;}
#t4w_2{left:790px;top:1027px;}
#t4x_2{left:811px;top:1027px;}
#t4y_2{left:483px;top:1041px;word-spacing:3.6px;}
#t4z_2{left:723px;top:1041px;word-spacing:28.4px;}
#t50_2{left:790px;top:1041px;}
#t51_2{left:811px;top:1041px;}
#t52_2{left:483px;top:1055px;word-spacing:3.8px;}
#t53_2{left:723px;top:1055px;word-spacing:28.4px;}
#t54_2{left:790px;top:1055px;}
#t55_2{left:811px;top:1055px;}
#t56_2{left:495px;top:1079px;letter-spacing:-0.7px;}
#t57_2{left:718px;top:1079px;word-spacing:4.2px;}
#t58_2{left:785px;top:1079px;word-spacing:3.8px;}
#t59_2{left:470px;top:1103px;letter-spacing:0.5px;word-spacing:3.2px;}
#t5a_2{left:470px;top:1117px;letter-spacing:5.9px;}
#t5b_2{left:487px;top:1117px;}
#t5c_2{left:496px;top:1117px;}
#t5d_2{left:225px;top:36px;word-spacing:4.7px;}
#t5e_2{left:805px;top:36px;}

.s13_2{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMLB-AdvPSA35B2;
	color: rgb(0,0,0);
}

.s8_2{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMIF-AdvPSA35F2;
	color: rgb(195,16,47);
}

.s9_2{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMLA-AdvPSA35E2;
	color: rgb(0,0,0);
}

.s10_2{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMJM-AdvPS_UVCL2;
	color: rgb(0,0,0);
}

.s4_2{
	FONT-SIZE: 67px;
	FONT-FAMILY: LBJMIF-AdvPSA35F2;
	color: rgb(0,0,0);
}

.s1_2{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: LBJMII-AdvPSNCS-R2;
	color: rgb(0,0,0);
}

.s12_2{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMJL-AdvP4C4E512;
	color: rgb(0,0,0);
}

.s11_2{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMJJ-AdvPS44A44B2;
	color: rgb(0,0,0);
}

.s7_2{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMIJ-AdvP4C4E742;
	color: rgb(0,0,0);
}

.s6_2{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMKP-AdvPSSym2;
	color: rgb(0,0,0);
}

.s14_2{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMIF-AdvPSA35F2;
	color: rgb(0,0,0);
}

.s3_2{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: LBJMIJ-AdvP4C4E742;
	color: rgb(0,0,0);
}

.s5_2{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMII-AdvPSNCS-R2;
	color: rgb(0,0,0);
}

.s2_2{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: LBJMII-AdvPSNCS-R2;
	color: rgb(0,0,0);
}

.v1_2{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

#form2_1{	border-style:none;	z-index:2;	position: absolute;	left:570px;	top:973px;	width:6px;	height:11px;	text-align:left;	background: transparent;	font:normal 7px Arial, Helvetica, sans-serif;}
#form2_2{	border-style:none;	z-index:2;	position: absolute;	left:469px;	top:1119px;	width:8px;	height:11px;	text-align:left;	background: transparent;	font:normal 7px Arial, Helvetica, sans-serif;}
#form2_3{	border-style:none;	z-index:2;	position: absolute;	left:821px;	top:827px;	width:8px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form2_4{	border-style:none;	z-index:2;	position: absolute;	left:235px;	top:371px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_5{	border-style:none;	z-index:2;	position: absolute;	left:289px;	top:408px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_6{	border-style:none;	z-index:2;	position: absolute;	left:251px;	top:371px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_7{	border-style:none;	z-index:2;	position: absolute;	left:161px;	top:281px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_8{	border-style:none;	z-index:2;	position: absolute;	left:156px;	top:573px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_9{	border-style:none;	z-index:2;	position: absolute;	left:165px;	top:701px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_10{	border-style:none;	z-index:2;	position: absolute;	left:153px;	top:610px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_11{	border-style:none;	z-index:2;	position: absolute;	left:177px;	top:573px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_12{	border-style:none;	z-index:2;	position: absolute;	left:417px;	top:336px;	width:17px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_13{	border-style:none;	z-index:2;	position: absolute;	left:177px;	top:536px;	width:31px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form2_14{	border-style:none;	z-index:2;	position: absolute;	left:517px;	top:688px;	width:52px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts2" type="text/css" >

@font-face {
	font-family: LBJMKP-AdvPSSym2;
	src: url("2/fonts/LBJMKP-AdvPSSym.woff") format("woff");
}

@font-face {
	font-family: LBJMJJ-AdvPS44A44B2;
	src: url("2/fonts/LBJMJJ-AdvPS44A44B.woff") format("woff");
}

@font-face {
	font-family: LBJMJM-AdvPS_UVCL2;
	src: url("2/fonts/LBJMJM-AdvPS_UVCL.woff") format("woff");
}

@font-face {
	font-family: LBJMIJ-AdvP4C4E742;
	src: url("2/fonts/LBJMIJ-AdvP4C4E74.woff") format("woff");
}

@font-face {
	font-family: LBJMIF-AdvPSA35F2;
	src: url("2/fonts/LBJMIF-AdvPSA35F.woff") format("woff");
}

@font-face {
	font-family: LBJMJL-AdvP4C4E512;
	src: url("2/fonts/LBJMJL-AdvP4C4E51.woff") format("woff");
}

@font-face {
	font-family: LBJMLA-AdvPSA35E2;
	src: url("2/fonts/LBJMLA-AdvPSA35E.woff") format("woff");
}

@font-face {
	font-family: LBJMII-AdvPSNCS-R2;
	src: url("2/fonts/LBJMII-AdvPSNCS-R.woff") format("woff");
}

@font-face {
	font-family: LBJMLB-AdvPSA35B2;
	src: url("2/fonts/LBJMLB-AdvPSA35B.woff") format("woff");
}

</style>
<div id="t1_2" class="t s1_2">refers to synthetic testosterone derivatives not used</div>
<div id="t2_2" class="t s1_2">for clinical management of hypogonadism.</div>
<div id="t3_2" class="t s1_2">Since the Bay Area Laboratory Co-Operative</div>
<div id="t4_2" class="t s1_2">(BALCO) scandal in 2003, which brought AAS use</div>
<div id="t5_2" class="t s1_2">by professional and Olympic athletes into the</div>
<div id="t6_2" class="t s1_2">media, the illicit use of performance enhancing</div>
<div id="t7_2" class="t s1_2">drugs has become widely recognized. Initially</div>
<div id="t8_2" class="t s1_2">popularized by bodybuilders and athletes in the</div>
<div id="t9_2" class="t s1_2">1970s, AASs are currently used most often to</div>
<div id="ta_2" class="t s1_2">increase muscular development or enhance athletic</div>
<div id="tb_2" class="t s1_2">performance.</div>
<div id="tc_2" class="t v1_2 s2_2">3</div>
<div id="td_2" class="t s1_2">Middle-aged men seeking rejuvena-</div>
<div id="te_2" class="t s1_2">tion comprise a new demographic of AAS users that</div>
<div id="tf_2" class="t s1_2">recently appeared. It was estimated that there are</div>
<div id="tg_2" class="t s1_2">up to 3 million AAS users in the United States.</div>
<div id="th_2" class="t v1_2 s2_2">4,5</div>
<div id="ti_2" class="t s1_2">Multiple studies show that 4% to 6% of high school</div>
<div id="tj_2" class="t s1_2">males have used AASs.</div>
<div id="tk_2" class="t v1_2 s2_2">6</div>
<div id="tl_2" class="t v1_2 s3_2">±</div>
<div id="tm_2" class="t v1_2 s2_2">8</div>
<div id="tn_2" class="t s1_2">Most large epidemiolog-</div>
<div id="to_2" class="t s1_2">ical studies estimate that the lifetime prevalence of</div>
<div id="tp_2" class="t s1_2">AAS use in men is at least 3%.</div>
<div id="tq_2" class="t v1_2 s2_2">9</div>
<div id="tr_2" class="t s1_2">AASs are known to cause hypogonadotropic</div>
<div id="ts_2" class="t s1_2">hypogonadism as a result of suppressing gonado-</div>
<div id="tt_2" class="t s1_2">tropin releasing hormone, luteinizing hormone</div>
<div id="tu_2" class="t s1_2">and follicle-stimulating hormone. The duration of</div>
<div id="tv_2" class="t s1_2">this</div>
<div id="tw_2" class="t s1_2">ASIH</div>
<div id="tx_2" class="t s1_2">is</div>
<div id="ty_2" class="t s1_2">unclear.</div>
<div id="tz_2" class="t s1_2">Some</div>
<div id="t10_2" class="t s1_2">studies</div>
<div id="t11_2" class="t s1_2">suggest</div>
<div id="t12_2" class="t s1_2">that ASIH lasts only 4 to 12 months after AAS</div>
<div id="t13_2" class="t s1_2">discontinuation</div>
<div id="t14_2" class="t v1_2 s2_2">10,11</div>
<div id="t15_2" class="t s1_2">but others describe a subset of</div>
<div id="t16_2" class="t s1_2">men with long-term or permanent gonadotropin</div>
<div id="t17_2" class="t s1_2">suppression.</div>
<div id="t18_2" class="t v1_2 s2_2">12</div>
<div id="t19_2" class="t v1_2 s3_2">±</div>
<div id="t1a_2" class="t v1_2 s2_2">15</div>
<div id="t1b_2" class="t s1_2">Depending on the cumulative</div>
<div id="t1c_2" class="t s1_2">dose and duration of AAS exposure ASIH may last</div>
<div id="t1d_2" class="t s1_2">indeﬁnitely.</div>
<div id="t1e_2" class="t v1_2 s2_2">16</div>
<div id="t1f_2" class="t s1_2">With increased focus in the lay press hypo-</div>
<div id="t1g_2" class="t s1_2">gonadism is increasingly diagnosed and treated in</div>
<div id="t1h_2" class="t s1_2">younger men. An idiopathic age related decrease in</div>
<div id="t1i_2" class="t s1_2">testosterone is recognized in 38.7% of men older</div>
<div id="t1j_2" class="t s1_2">than 45 years</div>
<div id="t1k_2" class="t v1_2 s2_2">17</div>
<div id="t1l_2" class="t s1_2">but the etiology of hypogonadism in</div>
<div id="t1m_2" class="t s1_2">younger men can be difﬁcult to identify. A potential</div>
<div id="t1n_2" class="t s1_2">etiology that is often overlooked is ASIH, especially</div>
<div id="t1o_2" class="t s1_2">in men who may have experimented with AAS in</div>
<div id="t1p_2" class="t s1_2">their youth and now seek evaluation for hypo-</div>
<div id="t1q_2" class="t s1_2">gonadal symptoms.</div>
<div id="t1r_2" class="t s1_2">Given the overall paucity of information on AAS</div>
<div id="t1s_2" class="t s1_2">use in hypogonadal men, we examined the impact,</div>
<div id="t1t_2" class="t s1_2">prevalence and prior use patterns of AAS in hypo-</div>
<div id="t1u_2" class="t s1_2">gonadal men.</div>
<div id="t1v_2" class="t s4_2">MATERIALS AND METHODS</div>
<div id="t1w_2" class="t s5_2">After receiving institutional review board approval we</div>
<div id="t1x_2" class="t s5_2">analyzed an established database of all 6,033 men evalu-</div>
<div id="t1y_2" class="t s5_2">ated for hypogonadism from 2005 to 2010 at an academic</div>
<div id="t1z_2" class="t s5_2">based urology practice. The charts of the 97 men who</div>
<div id="t20_2" class="t s5_2">presented with profound hypogonadism, deﬁned as total</div>
<div id="t21_2" class="t s5_2">testosterone 50 ng/dl or less, were reviewed for clinical</div>
<div id="t22_2" class="t s5_2">data. Given the high prevalence of men with profound</div>
<div id="t23_2" class="t s5_2">hypogonadism who acknowledged prior AAS use (42 of 97</div>
<div id="t24_2" class="t s5_2">or 43%), an anonymous survey was subsequently designed</div>
<div id="t25_2" class="t s5_2">to separately assess AAS use in the patient population</div>
<div id="t26_2" class="t s5_2">currently being treated for hypogonadism.</div>
<div id="t27_2" class="t s5_2">After receiving adjunctive institutional review board</div>
<div id="t28_2" class="t s5_2">approval the survey was distributed from September to</div>
<div id="t29_2" class="t s5_2">December 2012 to all men with hypogonadism listed as a</div>
<div id="t2a_2" class="t s5_2">diagnosis for the followup appointment. The survey was</div>
<div id="t2b_2" class="t s5_2">self-administered in the waiting room with written in-</div>
<div id="t2c_2" class="t s5_2">structions explaining the purpose of the questionnaire</div>
<div id="t2d_2" class="t s5_2">and emphasizing its conﬁdential, anonymous nature. For</div>
<div id="t2e_2" class="t s5_2">inclusion in analysis patients must have been currently</div>
<div id="t2f_2" class="t s5_2">receiving TRT for hypogonadism and must return for a</div>
<div id="t2g_2" class="t s5_2">followup appointment and be willing to participate.</div>
<div id="t2h_2" class="t s5_2">Surveys were excluded if patients were not currently on</div>
<div id="t2i_2" class="t s5_2">TRT or questions pertaining to previous AAS exposure</div>
<div id="t2j_2" class="t s5_2">were not completed.</div>
<div id="t2k_2" class="t s5_2">The ﬁrst portion of the survey assessed all patients</div>
<div id="t2l_2" class="t s5_2">receiving TRT and included basic patient demographics,</div>
<div id="t2m_2" class="t s5_2">such as age, sexual orientation, marital status, education</div>
<div id="t2n_2" class="t s5_2">level and income. Only men who reported prior AAS</div>
<div id="t2o_2" class="t s5_2">exposure were prompted to complete the second portion of</div>
<div id="t2p_2" class="t s5_2">the survey, which gathered data on the nature of prior</div>
<div id="t2q_2" class="t s5_2">AAS use, including age at ﬁrst use, drugs used previously</div>
<div id="t2r_2" class="t s5_2">and side effects while using AAS.</div>
<div id="t2s_2" class="t s5_2">Data were analyzed using the Student t test for scalar</div>
<div id="t2t_2" class="t s5_2">variables and the Fisher exact test for categorical vari-</div>
<div id="t2u_2" class="t s5_2">ables. Correlation analysis between variables was per-</div>
<div id="t2v_2" class="t s5_2">formed using the Spearman rank correlation and ORs</div>
<div id="t2w_2" class="t s5_2">were calculated as appropriate. Analysis was performed</div>
<div id="t2x_2" class="t s5_2">using Microsoft</div>
<div id="t2y_2" class="t s6_2">Ò</div>
<div id="t2z_2" class="t s5_2">Excel</div>
<div id="t30_2" class="t s6_2">Ò</div>
<div id="t31_2" class="t s5_2">and SPSS</div>
<div id="t32_2" class="t s6_2">Ò</div>
<div id="t33_2" class="t s5_2">, version 21 with</div>
<div id="t34_2" class="t s5_2">p</div>
<div id="t35_2" class="t s7_2">²</div>
<div id="t36_2" class="t s5_2">0.05 considered statistically signiﬁcant.</div>
<div id="t37_2" class="t s4_2">RESULTS</div>
<div id="t38_2" class="t s1_2">Profound hypogonadism, deﬁned as total testos-</div>
<div id="t39_2" class="t s1_2">terone 50 ng/dl or less, was identiﬁed in 97 men</div>
<div id="t3a_2" class="t s1_2">(1.6%) from a database of 6,033 seen from 2005 to</div>
<div id="t3b_2" class="t s1_2">2010 (table 1). Of these men 71 (73%) presented</div>
<div id="t3c_2" class="t s1_2">with symptoms of hypogonadism, while 26 (27%)</div>
<div id="t3d_2" class="t s8_2">Table 1.</div>
<div id="t3e_2" class="t s9_2">Database analysis of etiology in 97 of 6,033 men</div>
<div id="t3f_2" class="t s9_2">presenting with profound hypogonadism</div>
<div id="t3g_2" class="t s10_2">No. Pts (%)</div>
<div id="t3h_2" class="t s10_2">Total No. (%)</div>
<div id="t3i_2" class="t s10_2">Presenting symptom:</div>
<div id="t3j_2" class="t s11_2">e</div>
<div id="t3k_2" class="t s10_2">97 (1.6)*</div>
<div id="t3l_2" class="t s10_2">Hypogonadism</div>
<div id="t3m_2" class="t s10_2">71 (73)</div>
<div id="t3n_2" class="t s10_2">Infertility</div>
<div id="t3o_2" class="t s10_2">26 (27)</div>
<div id="t3p_2" class="t s10_2">Hypergonadotropic hypogonadism:</div>
<div id="t3q_2" class="t s10_2">Idiopathic primary testicular failure</div>
<div id="t3r_2" class="t s10_2">7</div>
<div id="t3s_2" class="t s10_2">(35)</div>
<div id="t3t_2" class="t s10_2">7</div>
<div id="t3u_2" class="t s10_2">(7)</div>
<div id="t3v_2" class="t s10_2">Surgical anorchia</div>
<div id="t3w_2" class="t s10_2">7</div>
<div id="t3x_2" class="t s10_2">(35)</div>
<div id="t3y_2" class="t s10_2">7</div>
<div id="t3z_2" class="t s10_2">(7)</div>
<div id="t40_2" class="t s10_2">Klinefelter</div>
<div id="t41_2" class="t s10_2">4</div>
<div id="t42_2" class="t s10_2">(20)</div>
<div id="t43_2" class="t s10_2">4</div>
<div id="t44_2" class="t s10_2">(4)</div>
<div id="t45_2" class="t s10_2">Traumatic anorchia</div>
<div id="t46_2" class="t s10_2">2</div>
<div id="t47_2" class="t s10_2">(10)</div>
<div id="t48_2" class="t s10_2">2</div>
<div id="t49_2" class="t s10_2">(2)</div>
<div id="t4a_2" class="t s10_2">Totals</div>
<div id="t4b_2" class="t s10_2">20 (20.6)</div>
<div id="t4c_2" class="t s10_2">97 (100)</div>
<div id="t4d_2" class="t s10_2">Prior AAS exposure†</div>
<div id="t4e_2" class="t s10_2">42</div>
<div id="t4f_2" class="t s10_2">(55)</div>
<div id="t4g_2" class="t s10_2">42 (43)</div>
<div id="t4h_2" class="t s10_2">Androgen deprivation therapy for prostate Ca</div>
<div id="t4i_2" class="t s10_2">12</div>
<div id="t4j_2" class="t s10_2">(16)</div>
<div id="t4k_2" class="t s10_2">12 (12)</div>
<div id="t4l_2" class="t s10_2">Idiopathic/unknown</div>
<div id="t4m_2" class="t s10_2">11</div>
<div id="t4n_2" class="t s10_2">(14)</div>
<div id="t4o_2" class="t s10_2">11 (11)</div>
<div id="t4p_2" class="t s10_2">Androgen deprivation therapy for hypersexuality</div>
<div id="t4q_2" class="t s10_2">6</div>
<div id="t4r_2" class="t s10_2">(8)</div>
<div id="t4s_2" class="t s10_2">6</div>
<div id="t4t_2" class="t s10_2">(6)</div>
<div id="t4u_2" class="t s10_2">Estrogen replacement for gender dysphoria</div>
<div id="t4v_2" class="t s10_2">2 (2.6)</div>
<div id="t4w_2" class="t s10_2">2</div>
<div id="t4x_2" class="t s10_2">(2)</div>
<div id="t4y_2" class="t s10_2">Pituitary adenoma</div>
<div id="t4z_2" class="t s10_2">2 (2.6)</div>
<div id="t50_2" class="t s10_2">2</div>
<div id="t51_2" class="t s10_2">(2)</div>
<div id="t52_2" class="t s10_2">Kallman syndrome</div>
<div id="t53_2" class="t s10_2">2 (2.6)</div>
<div id="t54_2" class="t s10_2">2</div>
<div id="t55_2" class="t s10_2">(2)</div>
<div id="t56_2" class="t s10_2">Totals</div>
<div id="t57_2" class="t s10_2">77 (79.4)</div>
<div id="t58_2" class="t s10_2">97 (100)</div>
<div id="t59_2" class="t s10_2">*Mean age 46 years.</div>
<div id="t5a_2" class="t s10_2">†p</div>
<div id="t5b_2" class="t s12_2">&lt;</div>
<div id="t5c_2" class="t s10_2">0.05.</div>
<div id="t5d_2" class="t s13_2">ANABOLIC STEROID INDUCED HYPOGONADISM IN YOUNG MEN</div>
<div id="t5e_2" class="t s14_2">2201</div>

<form>
<input type="button"  tabindex="13"  id="form2_1" name="14 0 R"  pdfFieldName="14 0 R" onclick="window.location.href='2.html';" style="cursor:pointer;"  title="Page 2" />
<input type="button"  tabindex="14"  id="form2_2" name="15 0 R"  pdfFieldName="15 0 R" onclick="window.location.href='2.html';" style="cursor:pointer;"  title="Page 2" />
<input type="button"  tabindex="12"  id="form2_3" name="13 0 R"  pdfFieldName="13 0 R" onclick="window.location.href='2.html';" style="cursor:pointer;"  title="Page 2" />
<input type="button"  tabindex="3"  id="form2_4" name="4 0 R"  pdfFieldName="4 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="5"  id="form2_5" name="6 0 R"  pdfFieldName="6 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="4"  id="form2_6" name="5 0 R"  pdfFieldName="5 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="1"  id="form2_7" name="2 0 R"  pdfFieldName="2 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="7"  id="form2_8" name="8 0 R"  pdfFieldName="8 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="10"  id="form2_9" name="11 0 R"  pdfFieldName="11 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="9"  id="form2_10" name="10 0 R"  pdfFieldName="10 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="8"  id="form2_11" name="9 0 R"  pdfFieldName="9 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="2"  id="form2_12" name="3 0 R"  pdfFieldName="3 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="6"  id="form2_13" name="7 0 R"  pdfFieldName="7 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="11"  id="form2_14" name="12 0 R"  pdfFieldName="12 0 R" onclick="window.location.href='2.html';" style="cursor:pointer;"  title="Page 2" />

</form>
<div id="pg2Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg2"><object width="893" height="1196" data="2/2.svg" type="image/svg+xml" id="pdf2" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 195;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_2");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
